Evidence map›Paper›PMID 38877552›Full record

ArticleMolecular autism2024

Enhanced hippocampal LTP but normal NMDA receptor and AMPA receptor function in a rat model of CDKL5 deficiency disorder.

Laura Simões de Oliveira, Heather E O'Leary, Sarfaraz Nawaz, Rita Loureiro, Elizabeth C Davenport, Paul Baxter, Susana R Louros, Owen Dando, Emma Perkins, Julien Peltier and 9 more

Abstract read
In one paragraph

Article in Molecular autism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Epilepsy-Related CDKL5 Deficiency Slows Synaptic Vesicle Endocytosis in Central Nerve Terminals.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Laura Simões de OliveiraCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Heather E O'LearySchool of Medicine, University of Colorado, Denver, CO, USA.
Sarfaraz NawazCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Rita LoureiroCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Elizabeth C DavenportCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Paul BaxterCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Susana R LourosCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Owen DandoCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Emma PerkinsCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Julien PeltierFaculty of Medical Sciences, Newcastle University Biosciences Institute, Newcastle upon Tyne, NE2 4HH, UK.
Matthias TrostFaculty of Medical Sciences, Newcastle University Biosciences Institute, Newcastle upon Tyne, NE2 4HH, UK.
Emily K OsterweilCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Giles E HardinghamCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Michael A CousinCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Sumantra ChattarjiCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Sam A BookerCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Tim A BenkeSchool of Medicine, University of Colorado, Denver, CO, USA. tim.benke@cuanschutz.edu.
David J A WyllieCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK. david.j.a.wyllie@ed.ac.uk.
Peter C KindCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK. p.kind@ed.ac.uk.

Funding

Development of Psychopathology, Psychobiology, & BehaviorT32MH015442 · NIMH · UNIVERSITY OF COLORADO DENVER · PI JASON R TREGELLAS · 1985 to 2026
$10.2M
NIMH NIH HHS T32 MH015442Simons Foundation Autism Research Initiative 529085Wellcome Trust 204954/Z/16/Z
6 · The paper itself

Abstract

backgroundMutations in the X-linked gene cyclin-dependent kinase-like 5 (CDKL5) cause a severe neurological disorder characterised by early-onset epileptic seizures, autism and intellectual disability (ID). Impaired hippocampal function has been implicated in other models of monogenic forms of autism spectrum disorders and ID and is often linked to epilepsy and behavioural abnormalities. Many individuals with CDKL5 deficiency disorder (CDD) have null mutations and complete loss of CDKL5 protein, therefore in the current study we used a Cdkl5

methodsTo allow cross-species comparisons of phenotypes associated with the loss of CDKL5, we generated a loss of function mutation in exon 8 of the rat Cdkl5 gene and assessed the impact of the loss of CDLK5 using a combination of extracellular and whole-cell electrophysiological recordings, biochemistry, and histology.

resultsOur results indicate that CA1 hippocampal long-term potentiation (LTP) is enhanced in slices prepared from juvenile, but not adult, Cdkl5

conclusionsOur data indicate a role for CDKL5 in hippocampal synaptic function and raise the possibility that altered intracellular signalling rather than synaptic deficits contribute to the altered plasticity. LIMITATIONS: This study has focussed on the electrophysiological and anatomical properties of hippocampal CA1 PCs across early postnatal development. Studies involving other brain regions, older animals and behavioural phenotypes associated with the loss of CDKL5 are needed to understand the pathophysiology of CDD.

Indexed as

Disease Models, AnimalLong-Term PotentiationProtein Serine-Threonine KinasesReceptors, AMPAReceptors, N-Methyl-D-AspartateSpasms, InfantileAnimalsCA1 Region, HippocampalEpileptic SyndromesExcitatory Postsynaptic PotentialsGenetic Diseases, X-LinkedHippocampusMalePyramidal CellsRatsSynapsesCDKL5 protein, ratProtein Serine-Threonine KinasesReceptors, AMPAReceptors, N-Methyl-D-AspartateAMPA receptorCDKL5hippocampusintrinsic propertiesNMDA receptorratsynaptic plasticity

Identifiers

PMID38877552
PMCPMC11177379

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.